nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Chills—Imiquimod—skin cancer	0.00362	0.00362	CcSEcCtD
Remifentanil—Arrhythmia—Imiquimod—skin cancer	0.0036	0.0036	CcSEcCtD
Remifentanil—Disorientation—Fluorouracil—skin cancer	0.00359	0.00359	CcSEcCtD
Remifentanil—Cough—Vemurafenib—skin cancer	0.00359	0.00359	CcSEcCtD
Remifentanil—Bronchospasm—Bleomycin—skin cancer	0.00352	0.00352	CcSEcCtD
Remifentanil—Erythema—Imiquimod—skin cancer	0.00351	0.00351	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00348	0.00348	CcSEcCtD
Remifentanil—Oliguria—Docetaxel—skin cancer	0.00347	0.00347	CcSEcCtD
Remifentanil—Vomiting—Vismodegib—skin cancer	0.00345	0.00345	CcSEcCtD
Remifentanil—Rash—Vismodegib—skin cancer	0.00343	0.00343	CcSEcCtD
Remifentanil—Amnesia—Fluorouracil—skin cancer	0.00342	0.00342	CcSEcCtD
Remifentanil—Dermatitis—Vismodegib—skin cancer	0.00342	0.00342	CcSEcCtD
Remifentanil—Anaphylactic shock—Vemurafenib—skin cancer	0.00336	0.00336	CcSEcCtD
Remifentanil—Dysphagia—Dactinomycin—skin cancer	0.00334	0.00334	CcSEcCtD
Remifentanil—Nervous system disorder—Vemurafenib—skin cancer	0.00329	0.00329	CcSEcCtD
Remifentanil—Skin disorder—Vemurafenib—skin cancer	0.00326	0.00326	CcSEcCtD
Remifentanil—Nausea—Vismodegib—skin cancer	0.00323	0.00323	CcSEcCtD
Remifentanil—Agitation—Imiquimod—skin cancer	0.00322	0.00322	CcSEcCtD
Remifentanil—Pneumonia—Bleomycin—skin cancer	0.00321	0.00321	CcSEcCtD
Remifentanil—Hypokalaemia—Temozolomide—skin cancer	0.00318	0.00318	CcSEcCtD
Remifentanil—Syncope—Imiquimod—skin cancer	0.00315	0.00315	CcSEcCtD
Remifentanil—Hypotension—Vemurafenib—skin cancer	0.00314	0.00314	CcSEcCtD
Remifentanil—Loss of consciousness—Imiquimod—skin cancer	0.00308	0.00308	CcSEcCtD
Remifentanil—Cough—Imiquimod—skin cancer	0.00306	0.00306	CcSEcCtD
Remifentanil—Cardiac arrest—Fluorouracil—skin cancer	0.00306	0.00306	CcSEcCtD
Remifentanil—Haematuria—Bleomycin—skin cancer	0.00304	0.00304	CcSEcCtD
Remifentanil—Convulsion—Imiquimod—skin cancer	0.00304	0.00304	CcSEcCtD
Remifentanil—Hypertension—Imiquimod—skin cancer	0.00303	0.00303	CcSEcCtD
Remifentanil—Dysphagia—Temozolomide—skin cancer	0.00302	0.00302	CcSEcCtD
Remifentanil—Pneumonia—Dactinomycin—skin cancer	0.00299	0.00299	CcSEcCtD
Remifentanil—Anxiety—Imiquimod—skin cancer	0.00298	0.00298	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00297	0.00297	CcSEcCtD
Remifentanil—Dry mouth—Imiquimod—skin cancer	0.00292	0.00292	CcSEcCtD
Remifentanil—Bronchitis—Temozolomide—skin cancer	0.0029	0.0029	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Vemurafenib—skin cancer	0.0029	0.0029	CcSEcCtD
Remifentanil—Haemoglobin—Bleomycin—skin cancer	0.00288	0.00288	CcSEcCtD
Remifentanil—Nasopharyngitis—Fluorouracil—skin cancer	0.00288	0.00288	CcSEcCtD
Remifentanil—Constipation—Vemurafenib—skin cancer	0.00287	0.00287	CcSEcCtD
Remifentanil—Oedema—Imiquimod—skin cancer	0.00286	0.00286	CcSEcCtD
Remifentanil—Haemorrhage—Bleomycin—skin cancer	0.00286	0.00286	CcSEcCtD
Remifentanil—Pulmonary oedema—Docetaxel—skin cancer	0.00285	0.00285	CcSEcCtD
Remifentanil—Dysuria—Temozolomide—skin cancer	0.00282	0.00282	CcSEcCtD
Remifentanil—Shock—Imiquimod—skin cancer	0.00282	0.00282	CcSEcCtD
Remifentanil—Nervous system disorder—Imiquimod—skin cancer	0.00281	0.00281	CcSEcCtD
Remifentanil—Tachycardia—Imiquimod—skin cancer	0.00279	0.00279	CcSEcCtD
Remifentanil—Skin disorder—Imiquimod—skin cancer	0.00278	0.00278	CcSEcCtD
Remifentanil—Dysphagia—Fluorouracil—skin cancer	0.00278	0.00278	CcSEcCtD
Remifentanil—Hyperhidrosis—Imiquimod—skin cancer	0.00277	0.00277	CcSEcCtD
Remifentanil—Hyperglycaemia—Temozolomide—skin cancer	0.00272	0.00272	CcSEcCtD
Remifentanil—Pneumonia—Temozolomide—skin cancer	0.00271	0.00271	CcSEcCtD
Remifentanil—Flushing—Bleomycin—skin cancer	0.00266	0.00266	CcSEcCtD
Remifentanil—Body temperature increased—Vemurafenib—skin cancer	0.00265	0.00265	CcSEcCtD
Remifentanil—Pharyngitis—Dactinomycin—skin cancer	0.00265	0.00265	CcSEcCtD
Remifentanil—Paraesthesia—Imiquimod—skin cancer	0.00257	0.00257	CcSEcCtD
Remifentanil—Chills—Bleomycin—skin cancer	0.00257	0.00257	CcSEcCtD
Remifentanil—Dyspnoea—Imiquimod—skin cancer	0.00255	0.00255	CcSEcCtD
Remifentanil—Somnolence—Imiquimod—skin cancer	0.00254	0.00254	CcSEcCtD
Remifentanil—Dyspepsia—Imiquimod—skin cancer	0.00252	0.00252	CcSEcCtD
Remifentanil—Pneumonia—Fluorouracil—skin cancer	0.00249	0.00249	CcSEcCtD
Remifentanil—Erythema—Bleomycin—skin cancer	0.00249	0.00249	CcSEcCtD
Remifentanil—Flushing—Dactinomycin—skin cancer	0.00248	0.00248	CcSEcCtD
Remifentanil—Hypersensitivity—Vemurafenib—skin cancer	0.00247	0.00247	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Imiquimod—skin cancer	0.00247	0.00247	CcSEcCtD
Remifentanil—Atrial fibrillation—Docetaxel—skin cancer	0.00245	0.00245	CcSEcCtD
Remifentanil—Visual disturbance—Docetaxel—skin cancer	0.00245	0.00245	CcSEcCtD
Remifentanil—Pain—Imiquimod—skin cancer	0.00245	0.00245	CcSEcCtD
Remifentanil—Renal impairment—Docetaxel—skin cancer	0.00244	0.00244	CcSEcCtD
Remifentanil—Haemoglobin—Temozolomide—skin cancer	0.00243	0.00243	CcSEcCtD
Remifentanil—Haemorrhage—Temozolomide—skin cancer	0.00241	0.00241	CcSEcCtD
Remifentanil—Hallucination—Temozolomide—skin cancer	0.0024	0.0024	CcSEcCtD
Remifentanil—Pharyngitis—Temozolomide—skin cancer	0.0024	0.0024	CcSEcCtD
Remifentanil—Chills—Dactinomycin—skin cancer	0.0024	0.0024	CcSEcCtD
Remifentanil—Pruritus—Vemurafenib—skin cancer	0.00237	0.00237	CcSEcCtD
Remifentanil—Feeling abnormal—Imiquimod—skin cancer	0.00236	0.00236	CcSEcCtD
Remifentanil—Visual impairment—Temozolomide—skin cancer	0.00233	0.00233	CcSEcCtD
Remifentanil—Erythema—Dactinomycin—skin cancer	0.00232	0.00232	CcSEcCtD
Remifentanil—Anaemia—Bleomycin—skin cancer	0.0023	0.0023	CcSEcCtD
Remifentanil—Diarrhoea—Vemurafenib—skin cancer	0.0023	0.0023	CcSEcCtD
Remifentanil—Urticaria—Imiquimod—skin cancer	0.00227	0.00227	CcSEcCtD
Remifentanil—Body temperature increased—Imiquimod—skin cancer	0.00226	0.00226	CcSEcCtD
Remifentanil—Flushing—Temozolomide—skin cancer	0.00224	0.00224	CcSEcCtD
Remifentanil—Cardiac disorder—Temozolomide—skin cancer	0.00224	0.00224	CcSEcCtD
Remifentanil—Haemoglobin—Fluorouracil—skin cancer	0.00224	0.00224	CcSEcCtD
Remifentanil—Haemorrhage—Fluorouracil—skin cancer	0.00222	0.00222	CcSEcCtD
Remifentanil—Dizziness—Vemurafenib—skin cancer	0.00222	0.00222	CcSEcCtD
Remifentanil—Pharyngitis—Fluorouracil—skin cancer	0.00221	0.00221	CcSEcCtD
Remifentanil—Angiopathy—Temozolomide—skin cancer	0.00219	0.00219	CcSEcCtD
Remifentanil—Immune system disorder—Temozolomide—skin cancer	0.00218	0.00218	CcSEcCtD
Remifentanil—Mediastinal disorder—Temozolomide—skin cancer	0.00218	0.00218	CcSEcCtD
Remifentanil—Cough—Bleomycin—skin cancer	0.00217	0.00217	CcSEcCtD
Remifentanil—Chills—Temozolomide—skin cancer	0.00217	0.00217	CcSEcCtD
Remifentanil—Anaemia—Dactinomycin—skin cancer	0.00215	0.00215	CcSEcCtD
Remifentanil—Vomiting—Vemurafenib—skin cancer	0.00213	0.00213	CcSEcCtD
Remifentanil—Rash—Vemurafenib—skin cancer	0.00212	0.00212	CcSEcCtD
Remifentanil—Dermatitis—Vemurafenib—skin cancer	0.00211	0.00211	CcSEcCtD
Remifentanil—Hypersensitivity—Imiquimod—skin cancer	0.00211	0.00211	CcSEcCtD
Remifentanil—Headache—Vemurafenib—skin cancer	0.0021	0.0021	CcSEcCtD
Remifentanil—Erythema—Temozolomide—skin cancer	0.0021	0.0021	CcSEcCtD
Remifentanil—Nasopharyngitis—Docetaxel—skin cancer	0.00208	0.00208	CcSEcCtD
Remifentanil—Confusional state—Bleomycin—skin cancer	0.00205	0.00205	CcSEcCtD
Remifentanil—Anaphylactic shock—Bleomycin—skin cancer	0.00203	0.00203	CcSEcCtD
Remifentanil—Oedema—Bleomycin—skin cancer	0.00203	0.00203	CcSEcCtD
Remifentanil—Pruritus—Imiquimod—skin cancer	0.00203	0.00203	CcSEcCtD
Remifentanil—Dysphagia—Docetaxel—skin cancer	0.00201	0.00201	CcSEcCtD
Remifentanil—Nausea—Vemurafenib—skin cancer	0.00199	0.00199	CcSEcCtD
Remifentanil—Thrombocytopenia—Bleomycin—skin cancer	0.00199	0.00199	CcSEcCtD
Remifentanil—Arrhythmia—Fluorouracil—skin cancer	0.00199	0.00199	CcSEcCtD
Remifentanil—Bronchospasm—Docetaxel—skin cancer	0.00197	0.00197	CcSEcCtD
Remifentanil—Tremor—Temozolomide—skin cancer	0.00197	0.00197	CcSEcCtD
Remifentanil—Diarrhoea—Imiquimod—skin cancer	0.00196	0.00196	CcSEcCtD
Remifentanil—Anaemia—Temozolomide—skin cancer	0.00194	0.00194	CcSEcCtD
Remifentanil—Erythema—Fluorouracil—skin cancer	0.00194	0.00194	CcSEcCtD
Remifentanil—Agitation—Temozolomide—skin cancer	0.00193	0.00193	CcSEcCtD
Remifentanil—Hypotension—Bleomycin—skin cancer	0.0019	0.0019	CcSEcCtD
Remifentanil—Oedema—Dactinomycin—skin cancer	0.0019	0.0019	CcSEcCtD
Remifentanil—Dizziness—Imiquimod—skin cancer	0.00189	0.00189	CcSEcCtD
Remifentanil—Thrombocytopenia—Dactinomycin—skin cancer	0.00186	0.00186	CcSEcCtD
Remifentanil—Cough—Temozolomide—skin cancer	0.00183	0.00183	CcSEcCtD
Remifentanil—Paraesthesia—Bleomycin—skin cancer	0.00183	0.00183	CcSEcCtD
Remifentanil—Convulsion—Temozolomide—skin cancer	0.00182	0.00182	CcSEcCtD
Remifentanil—Vomiting—Imiquimod—skin cancer	0.00182	0.00182	CcSEcCtD
Remifentanil—Hypertension—Temozolomide—skin cancer	0.00181	0.00181	CcSEcCtD
Remifentanil—Dyspnoea—Bleomycin—skin cancer	0.00181	0.00181	CcSEcCtD
Remifentanil—Rash—Imiquimod—skin cancer	0.0018	0.0018	CcSEcCtD
Remifentanil—Dermatitis—Imiquimod—skin cancer	0.0018	0.0018	CcSEcCtD
Remifentanil—Pneumonia—Docetaxel—skin cancer	0.0018	0.0018	CcSEcCtD
Remifentanil—Headache—Imiquimod—skin cancer	0.00179	0.00179	CcSEcCtD
Remifentanil—Anaemia—Fluorouracil—skin cancer	0.00179	0.00179	CcSEcCtD
Remifentanil—Anxiety—Temozolomide—skin cancer	0.00178	0.00178	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00178	0.00178	CcSEcCtD
Remifentanil—Renal failure—Docetaxel—skin cancer	0.00176	0.00176	CcSEcCtD
Remifentanil—Dry mouth—Temozolomide—skin cancer	0.00175	0.00175	CcSEcCtD
Remifentanil—Pain—Bleomycin—skin cancer	0.00174	0.00174	CcSEcCtD
Remifentanil—Confusional state—Temozolomide—skin cancer	0.00173	0.00173	CcSEcCtD
Remifentanil—Anaphylactic shock—Temozolomide—skin cancer	0.00172	0.00172	CcSEcCtD
Remifentanil—Oedema—Temozolomide—skin cancer	0.00172	0.00172	CcSEcCtD
Remifentanil—Nausea—Imiquimod—skin cancer	0.0017	0.0017	CcSEcCtD
Remifentanil—Nervous system disorder—Temozolomide—skin cancer	0.00168	0.00168	CcSEcCtD
Remifentanil—Thrombocytopenia—Temozolomide—skin cancer	0.00168	0.00168	CcSEcCtD
Remifentanil—Convulsion—Fluorouracil—skin cancer	0.00168	0.00168	CcSEcCtD
Remifentanil—Feeling abnormal—Bleomycin—skin cancer	0.00168	0.00168	CcSEcCtD
Remifentanil—Skin disorder—Temozolomide—skin cancer	0.00167	0.00167	CcSEcCtD
Remifentanil—Hyperhidrosis—Temozolomide—skin cancer	0.00166	0.00166	CcSEcCtD
Remifentanil—Pain—Dactinomycin—skin cancer	0.00162	0.00162	CcSEcCtD
Remifentanil—Urticaria—Bleomycin—skin cancer	0.00162	0.00162	CcSEcCtD
Remifentanil—Haemoglobin—Docetaxel—skin cancer	0.00161	0.00161	CcSEcCtD
Remifentanil—Body temperature increased—Bleomycin—skin cancer	0.00161	0.00161	CcSEcCtD
Remifentanil—Haemorrhage—Docetaxel—skin cancer	0.00161	0.00161	CcSEcCtD
Remifentanil—Confusional state—Fluorouracil—skin cancer	0.00159	0.00159	CcSEcCtD
Remifentanil—Pharyngitis—Docetaxel—skin cancer	0.00159	0.00159	CcSEcCtD
Remifentanil—Oedema—Fluorouracil—skin cancer	0.00158	0.00158	CcSEcCtD
Remifentanil—Anaphylactic shock—Fluorouracil—skin cancer	0.00158	0.00158	CcSEcCtD
Remifentanil—Feeling abnormal—Dactinomycin—skin cancer	0.00156	0.00156	CcSEcCtD
Remifentanil—Nervous system disorder—Fluorouracil—skin cancer	0.00155	0.00155	CcSEcCtD
Remifentanil—Thrombocytopenia—Fluorouracil—skin cancer	0.00155	0.00155	CcSEcCtD
Remifentanil—Visual impairment—Docetaxel—skin cancer	0.00155	0.00155	CcSEcCtD
Remifentanil—Tachycardia—Fluorouracil—skin cancer	0.00154	0.00154	CcSEcCtD
Remifentanil—Paraesthesia—Temozolomide—skin cancer	0.00154	0.00154	CcSEcCtD
Remifentanil—Dyspnoea—Temozolomide—skin cancer	0.00153	0.00153	CcSEcCtD
Remifentanil—Somnolence—Temozolomide—skin cancer	0.00152	0.00152	CcSEcCtD
Remifentanil—Dyspepsia—Temozolomide—skin cancer	0.00151	0.00151	CcSEcCtD
Remifentanil—Body temperature increased—Dactinomycin—skin cancer	0.0015	0.0015	CcSEcCtD
Remifentanil—Hypersensitivity—Bleomycin—skin cancer	0.0015	0.0015	CcSEcCtD
Remifentanil—Cardiac disorder—Docetaxel—skin cancer	0.00149	0.00149	CcSEcCtD
Remifentanil—Flushing—Docetaxel—skin cancer	0.00149	0.00149	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Temozolomide—skin cancer	0.00148	0.00148	CcSEcCtD
Remifentanil—Hypotension—Fluorouracil—skin cancer	0.00148	0.00148	CcSEcCtD
Remifentanil—Constipation—Temozolomide—skin cancer	0.00147	0.00147	CcSEcCtD
Remifentanil—Pain—Temozolomide—skin cancer	0.00147	0.00147	CcSEcCtD
Remifentanil—Angiopathy—Docetaxel—skin cancer	0.00146	0.00146	CcSEcCtD
Remifentanil—Immune system disorder—Docetaxel—skin cancer	0.00145	0.00145	CcSEcCtD
Remifentanil—Mediastinal disorder—Docetaxel—skin cancer	0.00145	0.00145	CcSEcCtD
Remifentanil—Chills—Docetaxel—skin cancer	0.00144	0.00144	CcSEcCtD
Remifentanil—Pruritus—Bleomycin—skin cancer	0.00144	0.00144	CcSEcCtD
Remifentanil—Arrhythmia—Docetaxel—skin cancer	0.00143	0.00143	CcSEcCtD
Remifentanil—Paraesthesia—Fluorouracil—skin cancer	0.00142	0.00142	CcSEcCtD
Remifentanil—Feeling abnormal—Temozolomide—skin cancer	0.00141	0.00141	CcSEcCtD
Remifentanil—Dyspnoea—Fluorouracil—skin cancer	0.00141	0.00141	CcSEcCtD
Remifentanil—Somnolence—Fluorouracil—skin cancer	0.00141	0.00141	CcSEcCtD
Remifentanil—Erythema—Docetaxel—skin cancer	0.0014	0.0014	CcSEcCtD
Remifentanil—Hypersensitivity—Dactinomycin—skin cancer	0.0014	0.0014	CcSEcCtD
Remifentanil—Dyspepsia—Fluorouracil—skin cancer	0.00139	0.00139	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00136	0.00136	CcSEcCtD
Remifentanil—Urticaria—Temozolomide—skin cancer	0.00136	0.00136	CcSEcCtD
Remifentanil—Body temperature increased—Temozolomide—skin cancer	0.00136	0.00136	CcSEcCtD
Remifentanil—Pain—Fluorouracil—skin cancer	0.00135	0.00135	CcSEcCtD
Remifentanil—Feeling abnormal—Fluorouracil—skin cancer	0.0013	0.0013	CcSEcCtD
Remifentanil—Diarrhoea—Dactinomycin—skin cancer	0.0013	0.0013	CcSEcCtD
Remifentanil—Vomiting—Bleomycin—skin cancer	0.00129	0.00129	CcSEcCtD
Remifentanil—Anaemia—Docetaxel—skin cancer	0.00129	0.00129	CcSEcCtD
Remifentanil—Rash—Bleomycin—skin cancer	0.00128	0.00128	CcSEcCtD
Remifentanil—Dermatitis—Bleomycin—skin cancer	0.00128	0.00128	CcSEcCtD
Remifentanil—Hypersensitivity—Temozolomide—skin cancer	0.00126	0.00126	CcSEcCtD
Remifentanil—Urticaria—Fluorouracil—skin cancer	0.00126	0.00126	CcSEcCtD
Remifentanil—Syncope—Docetaxel—skin cancer	0.00125	0.00125	CcSEcCtD
Remifentanil—Body temperature increased—Fluorouracil—skin cancer	0.00125	0.00125	CcSEcCtD
Remifentanil—Loss of consciousness—Docetaxel—skin cancer	0.00123	0.00123	CcSEcCtD
Remifentanil—Cough—Docetaxel—skin cancer	0.00122	0.00122	CcSEcCtD
Remifentanil—Pruritus—Temozolomide—skin cancer	0.00121	0.00121	CcSEcCtD
Remifentanil—Convulsion—Docetaxel—skin cancer	0.00121	0.00121	CcSEcCtD
Remifentanil—Nausea—Bleomycin—skin cancer	0.00121	0.00121	CcSEcCtD
Remifentanil—Hypertension—Docetaxel—skin cancer	0.00121	0.00121	CcSEcCtD
Remifentanil—Vomiting—Dactinomycin—skin cancer	0.00121	0.00121	CcSEcCtD
Remifentanil—Rash—Dactinomycin—skin cancer	0.0012	0.0012	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00118	0.00118	CcSEcCtD
Remifentanil—Diarrhoea—Temozolomide—skin cancer	0.00117	0.00117	CcSEcCtD
Remifentanil—Hypersensitivity—Fluorouracil—skin cancer	0.00116	0.00116	CcSEcCtD
Remifentanil—Dry mouth—Docetaxel—skin cancer	0.00116	0.00116	CcSEcCtD
Remifentanil—Confusional state—Docetaxel—skin cancer	0.00115	0.00115	CcSEcCtD
Remifentanil—Anaphylactic shock—Docetaxel—skin cancer	0.00114	0.00114	CcSEcCtD
Remifentanil—Oedema—Docetaxel—skin cancer	0.00114	0.00114	CcSEcCtD
Remifentanil—Dizziness—Temozolomide—skin cancer	0.00113	0.00113	CcSEcCtD
Remifentanil—Nausea—Dactinomycin—skin cancer	0.00113	0.00113	CcSEcCtD
Remifentanil—Shock—Docetaxel—skin cancer	0.00112	0.00112	CcSEcCtD
Remifentanil—Nervous system disorder—Docetaxel—skin cancer	0.00112	0.00112	CcSEcCtD
Remifentanil—Pruritus—Fluorouracil—skin cancer	0.00112	0.00112	CcSEcCtD
Remifentanil—Thrombocytopenia—Docetaxel—skin cancer	0.00112	0.00112	CcSEcCtD
Remifentanil—Tachycardia—Docetaxel—skin cancer	0.00111	0.00111	CcSEcCtD
Remifentanil—Skin disorder—Docetaxel—skin cancer	0.00111	0.00111	CcSEcCtD
Remifentanil—Vomiting—Temozolomide—skin cancer	0.00109	0.00109	CcSEcCtD
Remifentanil—Rash—Temozolomide—skin cancer	0.00108	0.00108	CcSEcCtD
Remifentanil—Diarrhoea—Fluorouracil—skin cancer	0.00108	0.00108	CcSEcCtD
Remifentanil—Dermatitis—Temozolomide—skin cancer	0.00108	0.00108	CcSEcCtD
Remifentanil—Headache—Temozolomide—skin cancer	0.00107	0.00107	CcSEcCtD
Remifentanil—Hypotension—Docetaxel—skin cancer	0.00107	0.00107	CcSEcCtD
Remifentanil—Dizziness—Fluorouracil—skin cancer	0.00105	0.00105	CcSEcCtD
Remifentanil—Paraesthesia—Docetaxel—skin cancer	0.00102	0.00102	CcSEcCtD
Remifentanil—Nausea—Temozolomide—skin cancer	0.00102	0.00102	CcSEcCtD
Remifentanil—Dyspnoea—Docetaxel—skin cancer	0.00102	0.00102	CcSEcCtD
Remifentanil—Somnolence—Docetaxel—skin cancer	0.00101	0.00101	CcSEcCtD
Remifentanil—Vomiting—Fluorouracil—skin cancer	0.001	0.001	CcSEcCtD
Remifentanil—Dyspepsia—Docetaxel—skin cancer	0.001	0.001	CcSEcCtD
Remifentanil—Rash—Fluorouracil—skin cancer	0.000997	0.000997	CcSEcCtD
Remifentanil—Dermatitis—Fluorouracil—skin cancer	0.000996	0.000996	CcSEcCtD
Remifentanil—Headache—Fluorouracil—skin cancer	0.00099	0.00099	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Docetaxel—skin cancer	0.000985	0.000985	CcSEcCtD
Remifentanil—Pain—Docetaxel—skin cancer	0.000976	0.000976	CcSEcCtD
Remifentanil—Constipation—Docetaxel—skin cancer	0.000976	0.000976	CcSEcCtD
Remifentanil—Feeling abnormal—Docetaxel—skin cancer	0.00094	0.00094	CcSEcCtD
Remifentanil—Nausea—Fluorouracil—skin cancer	0.000939	0.000939	CcSEcCtD
Remifentanil—Body temperature increased—Docetaxel—skin cancer	0.000902	0.000902	CcSEcCtD
Remifentanil—Hypersensitivity—Docetaxel—skin cancer	0.00084	0.00084	CcSEcCtD
Remifentanil—Pruritus—Docetaxel—skin cancer	0.000807	0.000807	CcSEcCtD
Remifentanil—Diarrhoea—Docetaxel—skin cancer	0.000781	0.000781	CcSEcCtD
Remifentanil—Dizziness—Docetaxel—skin cancer	0.000754	0.000754	CcSEcCtD
Remifentanil—Vomiting—Docetaxel—skin cancer	0.000725	0.000725	CcSEcCtD
Remifentanil—Rash—Docetaxel—skin cancer	0.000719	0.000719	CcSEcCtD
Remifentanil—Dermatitis—Docetaxel—skin cancer	0.000719	0.000719	CcSEcCtD
Remifentanil—Headache—Docetaxel—skin cancer	0.000715	0.000715	CcSEcCtD
Remifentanil—Nausea—Docetaxel—skin cancer	0.000678	0.000678	CcSEcCtD
